A detailed history of Biondo Investment Advisors, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Biondo Investment Advisors, LLC holds 24,430 shares of VRTX stock, worth $11.5 Million. This represents 1.71% of its overall portfolio holdings.

Number of Shares
24,430
Previous 665 3573.68%
Holding current value
$11.5 Million
Previous $277,000 4033.57%
% of portfolio
1.71%
Previous 0.04%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$392.81 - $485.53 $9.34 Million - $11.5 Million
23,765 Added 3573.68%
24,430 $11.5 Million
Q3 2023

Nov 09, 2023

SELL
$338.18 - $362.46 $33,818 - $36,246
-100 Reduced 13.07%
665 $231,000
Q1 2023

May 09, 2023

BUY
$283.23 - $323.1 $216,670 - $247,171
765 New
765 $241,000
Q2 2021

Aug 03, 2021

SELL
$187.49 - $221.1 $6 Million - $7.08 Million
-32,026 Closed
0 $0
Q1 2021

May 11, 2021

SELL
$207.02 - $241.31 $7.73 Million - $9.01 Million
-37,342 Reduced 53.83%
32,026 $6.88 Million
Q4 2020

Feb 04, 2021

BUY
$207.01 - $276.09 $1.12 Million - $1.5 Million
5,430 Added 8.49%
69,368 $16.4 Million
Q3 2020

Nov 05, 2020

SELL
$255.65 - $303.1 $233,919 - $277,336
-915 Reduced 1.41%
63,938 $17.4 Million
Q2 2020

Aug 07, 2020

SELL
$225.48 - $295.8 $59,752 - $78,387
-265 Reduced 0.41%
64,853 $18.8 Million
Q1 2020

May 08, 2020

SELL
$199.77 - $247.81 $310,043 - $384,601
-1,552 Reduced 2.33%
65,118 $15.5 Million
Q4 2019

Feb 06, 2020

BUY
$166.71 - $223.91 $2.51 Million - $3.37 Million
15,040 Added 29.13%
66,670 $14.6 Million
Q3 2019

Nov 05, 2019

SELL
$166.23 - $187.09 $701,490 - $789,519
-4,220 Reduced 7.56%
51,630 $8.75 Million
Q2 2019

Aug 06, 2019

BUY
$164.61 - $190.37 $148,149 - $171,333
900 Added 1.64%
55,850 $10.2 Million
Q1 2019

May 08, 2019

BUY
$163.73 - $194.7 $1.46 Million - $1.74 Million
8,930 Added 19.4%
54,950 $10.1 Million
Q4 2018

Feb 08, 2019

BUY
$151.91 - $192.21 $564,345 - $714,060
3,715 Added 8.78%
46,020 $7.63 Million
Q3 2018

Nov 07, 2018

BUY
$167.73 - $192.74 $1.31 Million - $1.5 Million
7,785 Added 22.55%
42,305 $8.15 Million
Q2 2018

Aug 02, 2018

BUY
$145.72 - $169.96 $79,417 - $92,628
545 Added 1.6%
34,520 $5.87 Million
Q1 2018

May 02, 2018

BUY
$151.6 - $177.13 $715,552 - $836,053
4,720 Added 16.13%
33,975 $5.54 Million
Q4 2017

Feb 07, 2018

BUY
$137.28 - $155.55 $24,710 - $27,999
180 Added 0.62%
29,255 $4.38 Million
Q3 2017

Nov 08, 2017

BUY
$148.13 - $162.24 $4.31 Million - $4.72 Million
29,075
29,075 $4.42 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $121B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Biondo Investment Advisors, LLC Portfolio

Follow Biondo Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Biondo Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Biondo Investment Advisors, LLC with notifications on news.